CARA vs. ^GSPC
Compare and contrast key facts about Cara Therapeutics, Inc. (CARA) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CARA or ^GSPC.
Correlation
The correlation between CARA and ^GSPC is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CARA vs. ^GSPC - Performance Comparison
Key characteristics
CARA:
-0.24
^GSPC:
0.46
CARA:
0.48
^GSPC:
0.77
CARA:
1.06
^GSPC:
1.11
CARA:
-0.29
^GSPC:
0.47
CARA:
-0.54
^GSPC:
1.94
CARA:
52.52%
^GSPC:
4.61%
CARA:
120.13%
^GSPC:
19.44%
CARA:
-99.17%
^GSPC:
-56.78%
CARA:
-98.26%
^GSPC:
-10.07%
Returns By Period
In the year-to-date period, CARA achieves a -0.61% return, which is significantly higher than ^GSPC's -6.06% return. Over the past 10 years, CARA has underperformed ^GSPC with an annualized return of -26.86%, while ^GSPC has yielded a comparatively higher 10.15% annualized return.
CARA
-0.61%
13.06%
89.14%
-25.92%
-50.27%
-26.86%
^GSPC
-6.06%
-2.95%
-4.87%
8.34%
13.98%
10.15%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CARA vs. ^GSPC — Risk-Adjusted Performance Rank
CARA
^GSPC
CARA vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cara Therapeutics, Inc. (CARA) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
CARA vs. ^GSPC - Drawdown Comparison
The maximum CARA drawdown since its inception was -99.17%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for CARA and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
CARA vs. ^GSPC - Volatility Comparison
Cara Therapeutics, Inc. (CARA) has a higher volatility of 20.99% compared to S&P 500 (^GSPC) at 14.23%. This indicates that CARA's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.